Evaluation of efficacy of intramuscular injection of pantothinic acid in patients with mild to moderate acne
Phase 3
Recruiting
- Conditions
- Acne.Acne vulgarisL70.0
- Registration Number
- IRCT20150825023753N19
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with mild to moderate acne
Patients have not received any systemic treatment in the last one month and have not received any local treatment in the last two weeks
Married women who agree to use physical methods of contraception such as condoms and IUDs during the study
Exclusion Criteria
Pregnant and lactating women
Patients with polycystic ovary syndrome
Lack of consent to continue studying
Use of herbal medicines
History of allergy to the studied drug
Allergy to adapalene gel
Inability to visit regularly to check response to treatment
Patients with severe acne
Existence of systemic disease including kidney and liver problems
Current use of dietary supplements for skin health
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acne severity. Timepoint: Base line, first month, second month. Method of measurement: Acne severity GAGS (Global Acne Grading System).
- Secondary Outcome Measures
Name Time Method Quality of life of the patients. Timepoint: Base line, first month, second month. Method of measurement: Dermatology Quality of Life Index.;Acne count. Timepoint: Base line, first month, second month. Method of measurement: Counting the acne lesions.